Glypican-3 as a Prognostic Factor in Patients With Hepatocellular Carcinoma Treated by Immunotherapy
Clinical trial NCT05263830 · RECRUITING
Trial details
- NCT number
- NCT05263830
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-08
- Primary completion
- 2029-09-08
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.